In every crypto cycle, capital does not move all at once. It rotates. Large names slow down first. Then attention shif ...

TDK has announced the release of the TDK‑Lambda TPS4500 series of industrial AC‑DC power supplies, offering a rated output of ...

Company believes that data from sunRIZE and the Expanded Access Program (EAP) provide evidence of activity of ersodetug in ...

U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated ...

By tracking biometrics like temperature, respiratory rate and heart rate, the Oura Ring can catch early signs of physical ...

InflaRx presented data analyses from a terminated Phase 3 study on the potential treatment for rare skin condition.

Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

SELLAS Life Sciences Virtual R&D Day -- October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 ...

In the first phase, the Election Commission called 70 candidates today. Of them, 51 candidates had their nominations restored, while appeals filed by 16 candidates were rejected, and three remained ...

SpliceBio has dosed the first patient in the Part B dose-expansion portion of its phase 1/2 ASTRA clinical trial ( ...

Polygon records daily burns of nearly 1 million POL from base fees, while 3.6 billion POL remains staked across the network.